Skip to main content

Table 1 Demographic and clinical profiles of the study population

From: On-going malaria transmission in The Gambia despite high coverage of control interventions: a nationwide cross-sectional survey

Variable N (%)
Age (N = 9,079)
 <5 years 2,477 (27.28)
 5–15 years 2,811 (30.96)
 >15 years 3,791 (41.76)
Gender (N = 9,094)
 Female 5,417 (59.57)
 Male 3,677 (40.43)
Anaemia (N = 8,991)
 No anaemia (>12.9 g/dl) 2,198 (24.45)
 Mild (11.0–12.9 g/dl) 3,783 (42.08)
 Moderate (8.0–10.9 g/dl) 2,671 (29.70)
 Severe (<8.0 g/dl) 339 (3.77)
Has received indoor residual spraying in past 1 year (N = 9,094)
 Yes 7,170 (78.84)
 No 1,924 (21.16)
Has slept under a LLIN the previous night (N = 8,621)
 Yes 8,244 (95.63)
 No 377 (4.37)
Has slept outdoors at night (N = 9,064)
 Yes 3,807 (42.0)
 No 5,257 (58.0)
Has used an LLIN outdoors at night (N = 3,689)
 Yes 1,405 (38.09)
 No 2,284 (61.91)
Has history of fever in the last 24 h (N = 9,094)
 Yes 4,195 (46.13)
 No 4,899 (53.87)
Presence of fever (axillary temperature ≥37.5 °C) (N = 9,094)
 Yes 498 (5.48)
 No 8,596 (94.52)
Has taken artemether-lumefantrine in past 2 weeks (N = 9,094)
 Yes 174 (1.91)
 No 8,920 (98.09)